science
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
Why this matters: new research or scientific developments with potential real-world impact.
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that people t
Read full story on Science Daily → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Science Daily alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop